RecallRadar

FDA Drug recall D-0656-2026

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 276…

On 2026-07-08 the FDA classified a Class II recall of Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 276… by Accord Healthcare, citing subpotent Drug.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0656-2026
ClassificationClass II
Statusongoing
Initiated2026-06-08
Published2026-07-08
Last updated2026-09-13 11:52 UTC
CompanyAccord Healthcare
DistributionUS

Product

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.

Reason

Subpotent Drug

Identifiers

ndc16729-458-15
ndc16729-458-17
ndc16729-447-15
ndc16729-447-17
ndc16729-448-15
ndc16729-448-17
ndc16729-449-15
ndc16729-449-17
ndc16729-451-15
ndc16729-451-17
ndc16729-450-15
ndc16729-450-17
ndc16729-452-15
ndc16729-452-17
ndc16729-453-15
ndc16729-453-17
ndc16729-454-15
ndc16729-454-17
ndc16729-455-15
ndc16729-455-17
ndc16729-456-15
ndc16729-456-17
ndc16729-457-15
ndc16729-457-17
code_infoLot # D2401522, Exp Date: 06/2026.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0656-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.